CAS 2170696-76-9

LysRs-IN-2

CAS: 2170696-76-9

LysRs-IN-2

Purity: ≥98%

Molecular weight: 355.31g/mol

Ref: 54-BUP05612

LysRs-in-2

CAS: 2170696-76-9

LysRs-in-2 is a protein inhibitor that is derived from ceftiofur, an antibiotic used in veterinary medicine. It has been shown to have anticancer properties by inducing apoptosis in cancer cells. LysRs-in-2 targets kinases, which are enzymes involved in cell signaling pathways that regulate cell growth and division. This analog has been tested on both Chinese hamster ovary cells and human tumor cells, demonstrating potent anticancer activity. Additionally, LysRs-in-2 has been found in urine samples of patients with cancer, suggesting its potential as a diagnostic marker for cancer detection. Further research is needed to fully understand the therapeutic potential of this promising compound.

Formula: C₁₇H₁₆F₃NO₄

Purity: Min. 95%

Molecular weight: 355.31 g/mol

Ref: 3D-VLD69676

LysRs-IN-2

CAS: 2170696-76-9

LysRs-IN-2 is a KRS inhibitor with antiparasitic effects and inhibits Plasmodium falciparum KRS , which can be used to study malaria infections.

Formula: C₁₇H₁₆F₃NO₄

Purity: 99.34%

Color and Shape: Solid

Molecular weight: 355.31

Ref: TM-T11920